Glen Harbor Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Glen Harbor Capital Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,656	Closed	-$58K	–	1315
2018 Q1	$58K	Sell	4,656 -14,000	-75%	-$170K	﹤0.01%	1214
2017 Q4	$261K	Sell	18,656 -9,344	-33%	-$137K	0.01%	888
2017 Q3	$470K	Sell	28,000 -3,488	-11%	-$56.8K	0.01%	615
2017 Q2	$530K	Sell	31,488 -10,512	-25%	-$157K	0.01%	578
2017 Q1	$651K	Hold	42,000	–	–	0.02%	489
2016 Q4	$628K	Buy	+42,000	New	+$590K	0.02%	446

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Glen Harbor Capital Management's OXFD Position: Q2 2018 in Review

Glen Harbor Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2018, closing a stake of 4,656 shares — an estimated $58K sold.

Glen Harbor Capital Management first reported a position in OXFD in Q4 2016 and held it in 6 quarters. The position peaked at $651K in Q1 2017. 77 funds tracked by Wall St. Rank hold OXFD as of Q2 2018.

Glen Harbor Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2018 after selling out during the quarter.
Glen Harbor Capital Management sold 4,656 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2018, an estimated $58K.
Glen Harbor Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2016 and held it in 6 quarters.
Glen Harbor Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $651K in Q1 2017.
77 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2018.

Based on Glen Harbor Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.